Stem Cell Transplant Complications Withdrawn Phase 4 Trials for Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DB14105)

IndicationStatusPhase
DBCOND0081111 (Stem Cell Transplant Complications)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03963999Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant PatientsDiagnostic